|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 295/185 | |
| C07C 237/22 | |||
| C07D 213/81 | |||
| C07D 233/90 | |||
| C07D 295/26 | |||
| A61K 31/166 | |||
| A61K 31/40 | |||
| A61K 31/4453 | |||
| A61K 31/495 | |||
| A61K 31/5375 | |||
| A61K 31/54 | |||
| A61P 35/00 |
| (11) | Number of the document | 3030323 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14834451.8 |
| Date of filing the European patent application | 2014-08-06 | |
| (97) | Date of publication of the European application | 2016-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/049906 |
| Date | 2014-08-06 |
| (87) | Number | WO 2015/021128 |
| Date | 2015-02-12 |
| (30) | Number | Date | Country code |
| 201361862759 P | 2013-08-06 | US | |
| 201461954276 P | 2014-03-17 | US |
| (72) |
MCCALL, John M., US
RIENHOFF, Jr. Hugh, Young, US
CLARE, Michael, US
|
| (73) |
Imago Biosciences Inc.,
2729 Debbie Court, San Carlos, CA 94070,
US
|
| (54) | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE |
| KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE |